BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29917189)

  • 1. Expressions and correlation analysis of HIF-1α, survivin and VEGF in patients with hepatocarcinoma.
    Tian QG; Wu YT; Liu Y; Zhang J; Song ZQ; Gao WF; Guo TK; He CH; Dai FR
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3378-3385. PubMed ID: 29917189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival.
    Huang GW; Yang LY; Lu WQ
    World J Gastroenterol; 2005 Mar; 11(11):1705-8. PubMed ID: 15786555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical research on the expression of three vascular regulatory factors in different morphological regions of Marjolin ulcer and their relationship with angiogenesis].
    Xia C; Chu ZG
    Zhonghua Shao Shang Za Zhi; 2019 Sep; 35(9):676-682. PubMed ID: 31594186
    [No Abstract]   [Full Text] [Related]  

  • 4. Upregulation of hypoxia inducible factor 1alpha mRNA is associated with elevated vascular endothelial growth factor expression and excessive angiogenesis and predicts a poor prognosis in gastric carcinoma.
    Ma J; Zhang L; Ru GQ; Zhao ZS; Xu WJ
    World J Gastroenterol; 2007 Mar; 13(11):1680-6. PubMed ID: 17461470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation of mRNA expression of hypoxia inducible factor-1alpha to biological features of pancreatic cancer].
    Wei HY; Chen LB; Wang CY
    Ai Zheng; 2005 Feb; 24(2):184-8. PubMed ID: 15694030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma.
    Kuwai T; Kitadai Y; Tanaka S; Onogawa S; Matsutani N; Kaio E; Ito M; Chayama K
    Int J Cancer; 2003 Jun; 105(2):176-81. PubMed ID: 12673675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expressions of hypoxia inducible factor-1alpha and vascular endothelial growth factor in human renal cell carcinoma].
    Shao ZQ; Zheng SB; Xiao YJ; Tan WL; Chen T; Qi H; Jiang YD; Yu ZC; Zhang HJ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):1034-6. PubMed ID: 16109571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the expression of HIF-1α and VEGF and prognostic implications in primary liver cancer.
    Guo LY; Zhu P; Jin XP
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of hypoxia-inducible factor-1-alpha, hypoxia-inducible factor-2alpha and vascular endothelial growth factor in sporadic clear cell renal cell renal cell carcinoma and their significance in the pathogenesis thereof].
    Zhang N; Gong K; Yang XY; Xin DQ; Na YQ
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(22):1526-9. PubMed ID: 16854277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor, hypoxia-inducible factor 1 alpha and CD34 expressions in early-stage gastric tumors: relationship with pathological factors and prognostic impact on survival.
    Cabuk D; Basaran G; Celikel C; Dane F; Yumuk PF; Iyikesici MS; Ekenel M; Turhal NS
    Oncology; 2007; 72(1-2):111-7. PubMed ID: 18025805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expressions of Survivin and vascular endothelial growth factor in hepatocellular carcinoma and their clinical significance].
    Cui F; Chen B; Chen JZ; Huang YX; Luo RC
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):761-3. PubMed ID: 18504198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H₂₂ murine hepatocarcinoma model.
    Sui W; Zhang Y; Wang Z; Wang Z; Jia Q; Wu L; Zhang W
    Oncol Rep; 2014 May; 31(5):2252-60. PubMed ID: 24647425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expressions of HIF-1α and KISS-1 in patients with liver cancer and correlation analysis.
    Song WW; Gui AP; Li W; Chen HS; Li JM
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4058-4063. PubMed ID: 29028096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of VEGF expression in oral squamous cell carcinomas: correlation with the mTOR-HIF-1α pathway.
    Naruse T; Kawasaki G; Yanamoto S; Mizuno A; Umeda M
    Anticancer Res; 2011 Dec; 31(12):4429-37. PubMed ID: 22199311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Up-regulated expressions of HIF-1α, VEGF and CD34 promote synovial angiogenesis in rats with adjuvant arthritis].
    Zhang X; Liu J; Wan L; Sun Y; Wang F; Qi Y; Huang C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Aug; 31(8):1053-6. PubMed ID: 26271978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
    Liang X; Yang D; Hu J; Hao X; Gao J; Mao Z
    Anticancer Res; 2008; 28(3A):1659-66. PubMed ID: 18630523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HIF-1alpha, HPSE and VEGF promote malignant progression of retinoblastoma].
    Wang XL; Niu YJ; Ma JM
    Zhonghua Yan Ke Za Zhi; 2010 Feb; 46(2):140-4. PubMed ID: 20388348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necrosis degree displayed in computed tomography images correlated with hypoxia and angiogenesis in breast cancer.
    Shan X; Wang D; Chen J; Xiao X; Jiang Y; Wang Y; Fan Y
    J Comput Assist Tomogr; 2013; 37(1):22-8. PubMed ID: 23321829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of hypoxia-inducible factor-1alpha and vessel endothelial growth factor in esophageal squamous cell carcinoma and clinico-pathological significance thereof].
    Yu ZT; Zhao HF; Shang XB
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2465-9. PubMed ID: 19080625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression levels of PTEN, HIF-1α, and VEGF as prognostic factors in ovarian cancer.
    Shen W; Li HL; Liu L; Cheng JX
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2596-2603. PubMed ID: 28678326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.